| Date Filed | Type | Description |
| 08/11/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 05/12/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/14/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/31/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 10/18/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 07/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/10/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/13/2022 |
SC 13D/A
| FOUNTAINHEAD CAPITAL MANAGEMENT LTD reports a 61.3% stake in VYCOR MEDICAL, INC. |
| 04/13/2022 |
4
| FOUNTAINHEAD CAPITAL MANAGEMENT LTD (10% Owner) has filed a Form 4 on VYCOR MEDICAL INC|
Txns:
| Acquired 535,714 shares
@ $0.085, valued at
$45.5k
|
|
| 04/13/2022 |
10-K
| Annual Report for the period ended December 31, 2021 |
| 04/01/2022 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 01/18/2022 |
4
| FOUNTAINHEAD CAPITAL MANAGEMENT LTD (10% Owner) has filed a Form 4 on VYCOR MEDICAL INC|
Txns:
| Acquired 535,714 shares
@ $0.097, valued at
$52k
|
|
| 11/12/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 10/08/2021 |
SC 13D/A
| FOUNTAINHEAD CAPITAL MANAGEMENT LTD reports a 59.2% stake in VYCOR MEDICAL, INC. |
| 10/08/2021 |
4
| FOUNTAINHEAD CAPITAL MANAGEMENT LTD (10% Owner) has filed a Form 4 on VYCOR MEDICAL INC|
Txns:
| Acquired 535,714 shares
@ $0.144, valued at
$77.1k
|
|
| 08/16/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 07/20/2021 |
SC 13D/A
| FOUNTAINHEAD CAPITAL MANAGEMENT LTD reports a 58.5% stake in VYCOR MEDICAL, INC. |
| 07/20/2021 |
4
| FOUNTAINHEAD CAPITAL MANAGEMENT LTD (10% Owner) has filed a Form 4 on VYCOR MEDICAL INC|
Txns:
| Acquired 535,714 shares
@ $0.14, valued at
$75k
|
|
| 05/14/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 04/08/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/08/2021 |
4
| Rush Lowell (Director) has filed a Form 4 on VYCOR MEDICAL INC|
Txns:
| Acquired 33,333 shares
@ $0.21, valued at
$7k
|
|
| 04/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2021 |
4
| GIRGENTI STEVEN (Director) has filed a Form 4 on VYCOR MEDICAL INC|
Txns:
| Unknown transaction of 33 shares
@ $0.21, valued at
$7 |
|
| 03/31/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 03/22/2021 |
8-K
| Quarterly results |
| 01/11/2021 |
4
| GIRGENTI STEVEN (Director) has filed a Form 4 on VYCOR MEDICAL INC|
Txns:
| Unknown transaction of 33 shares
@ $0.21, valued at
$7 |
|
| 01/11/2021 |
4
| Rush Lowell (Director) has filed a Form 4 on VYCOR MEDICAL INC|
Txns:
| Acquired 33,333 shares
@ $0.21, valued at
$7k
|
|
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/13/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
|